Published in Diabetologia on January 11, 2006
11C-dihydrotetrabenazine PET of the pancreas in subjects with long-standing type 1 diabetes and in healthy controls. J Nucl Med (2009) 1.99
Beta-cell mass and type 1 diabetes: going, going, gone? Diabetes (2008) 1.69
Preservation of beta-cell function in autoantibody-positive youth with diabetes. Diabetes Care (2009) 1.32
Evidence-informed clinical practice recommendations for treatment of type 1 diabetes complicated by problematic hypoglycemia. Diabetes Care (2015) 1.07
Insulin protein and proliferation in ductal cells in the transplanted pancreas of patients with type 1 diabetes and recurrence of autoimmunity. Diabetologia (2008) 0.97
Hyperglycaemia results from beta-cell dysfunction in critically ill children with respiratory and cardiovascular failure: a prospective observational study. Crit Care (2009) 0.96
Postprandial C-peptide to glucose ratio as a predictor of β-cell function and its usefulness for staged management of type 2 diabetes. J Diabetes Investig (2014) 0.93
Stem cell therapy to cure type 1 diabetes: from hype to hope. Stem Cells Transl Med (2013) 0.93
β-cell function and metabolic control in latent autoimmune diabetes in adults with early insulin versus conventional treatment: a 3-year follow-up. Eur J Endocrinol (2010) 0.89
Recurrence of autoimmunity following pancreas transplantation. Curr Diab Rep (2011) 0.88
Immunologic and metabolic biomarkers of β-cell destruction in the diagnosis of type 1 diabetes. Cold Spring Harb Perspect Med (2012) 0.85
Recovery of endocrine function after islet and pancreas transplantation. Curr Diab Rep (2012) 0.85
Residual β-Cell function 3-6 years after onset of type 1 diabetes reduces risk of severe hypoglycemia in children and adolescents. Diabetes Care (2013) 0.83
Beta-cell destruction and preservation in childhood and adult onset type 1 diabetes. Endocrine (2015) 0.83
Levels of C-peptide, body mass index and age, and their usefulness in classification of diabetes in relation to autoimmunity, in adults with newly diagnosed diabetes in Kronoberg, Sweden. Eur J Endocrinol (2012) 0.82
Glucose homeostasis in pre-diabetic NOD and lymphocyte-deficient NOD/SCID mice during gestation. Rev Diabet Stud (2010) 0.78
Common defects of mitochondria and iron in neurodegeneration and diabetes (MIND): a paradigm worth exploring. Biochem Pharmacol (2013) 0.77
Impact of Disease Duration on the Effects of Pramlintide in Type 1 Diabetes: A Post Hoc Analysis of Three Clinical Trials. Adv Ther (2016) 0.75
Residual C-peptide in patients with Type 1 diabetes and multiethnic backgrounds. Clinics (Sao Paulo) (2013) 0.75
2α-Methyl-19-nor-(20S)-1,25-dihydroxyvitamin D(3) protects the insulin 2 knockout non-obese diabetic mouse from developing type 1 diabetes without hypercalcaemia. Clin Exp Immunol (2011) 0.75
Insulitis in the pathogenesis of type 1 diabetes. Pediatr Diabetes (2016) 0.75
Progress and challenges for treating Type 1 diabetes. J Autoimmun (2016) 0.75
Human beta cell mass and function in diabetes: Recent advances in knowledge and technologies to understand disease pathogenesis. Mol Metab (2017) 0.75
OGTT 1h serum C-peptide to plasma glucose concentration ratio is more related to beta cell function and diabetes mellitus. Oncotarget (2017) 0.75
Quantification of the relationship between insulin sensitivity and beta-cell function in human subjects. Evidence for a hyperbolic function. Diabetes (1993) 5.70
Latent autoimmune diabetes in adults (LADA) should be less latent. Diabetologia (2005) 4.87
Insulin antibodies in insulin-dependent diabetics before insulin treatment. Science (1983) 4.16
Differential effects of anti-B7-1 and anti-B7-2 monoclonal antibody treatment on the development of diabetes in the nonobese diabetic mouse. J Exp Med (1995) 3.18
Familial hyperinsulinism caused by an activating glucokinase mutation. N Engl J Med (1998) 2.57
CD28/B7 regulation of Th1 and Th2 subsets in the development of autoimmune diabetes. Immunity (1996) 2.09
No risk of diabetes after insulin-shock treatment. Lancet (1992) 2.02
A novel micro-assay for insulin autoantibodies. J Autoimmun (1997) 1.90
Insulin autoantibodies measured by radioimmunoassay methodology are more related to insulin-dependent diabetes mellitus than those measured by enzyme-linked immunosorbent assay: results of the Fourth International Workshop on the Standardization of Insulin Autoantibody Measurement. J Clin Endocrinol Metab (1992) 1.70
Gestational diabetes: antepartum characteristics that predict postpartum glucose intolerance and type 2 diabetes in Latino women. Diabetes (1998) 1.63
Immunogenetic analysis suggests different pathogenesis for obese and lean African-Americans with diabetic ketoacidosis. Diabetes Care (1999) 1.52
Prognostic factors for the course of beta cell function in autoimmune diabetes. J Clin Endocrinol Metab (2000) 1.48
Arginine-stimulated acute phase of insulin and glucagon secretion in diabetic subjects. J Clin Invest (1976) 1.40
Correlations of in vivo beta-cell function tests with beta-cell mass and pancreatic insulin content in streptozocin-administered baboons. Diabetes (1991) 1.34
In vivo inhibition of glucagon secretion by paracrine beta cell activity in man. J Clin Invest (1981) 1.33
The effect of adrenergic blockade on the glucagon responses to starvation and hypoglycemia in man. J Clin Invest (1974) 1.29
Relationship of beta-cell function and autoantibodies to progression and nonprogression of subclinical type 1 diabetes: follow-up of the Seattle Family Study. Diabetes (1999) 1.26
Transcomplementation of HLA genes in IDDM. HLA-DQ alpha- and beta-chains produce hybrid molecules in DR3/4 heterozygotes. Diabetes (1987) 1.25
Long QT syndrome during high-dose cisapride. Arch Intern Med (1995) 1.20
A novel high-throughput method for accurate, rapid, and economical measurement of multiple type 1 diabetes autoantibodies. J Immunol Methods (2000) 1.18
Peripheral blood mononuclear cells of insulin-dependent diabetic patients respond to multiple islet cell proteins. J Immunol (1996) 1.18
Immunosuppressive effects of cyclosporin A on cloned T cells. J Immunol (1986) 1.16
Alcoholic ketoacidosis: clinical and laboratory presentation, pathophysiology and treatment. Clin Endocrinol Metab (1983) 1.15
Arginine-stimulated acute phase of insulin and glucagon secretion. I. in normal man. Diabetes (1975) 1.13
Interaction of beta-cell activity and IL-1 concentration and exposure time in isolated rat islets of Langerhans. Diabetes (1989) 1.13
Expression of GAD65 and islet cell antibody (ICA512) autoantibodies among cytoplasmic ICA+ relatives is associated with eligibility for the Diabetes Prevention Trial-Type 1. Diabetes (2001) 1.13
The contribution of insulin-dependent and insulin-independent glucose uptake to intravenous glucose tolerance in healthy human subjects. Diabetes (1994) 1.12
An antigen receptor-driven, interleukin 2-independent pathway for proliferation of murine cytolytic T lymphocyte clones. J Exp Med (1986) 1.12
Intermolecular antigen spreading occurs during the preclinical period of human type 1 diabetes. J Immunol (2001) 1.11
Repair of pancreatic beta-cells. A relevant phenomenon in early IDDM? Diabetes (1993) 1.09
Blockade of RAGE suppresses alloimmune reactions in vitro and delays allograft rejection in murine heart transplantation. Am J Transplant (2007) 1.07
Autoimmunity to insulin, beta cell dysfunction, and development of insulin-dependent diabetes mellitus. Diabetes (1986) 1.06
Treatment with anti-T-lymphocyte antibodies prevents induction of insulitis in mice given multiple doses of streptozocin. Diabetes (1987) 1.06
Variable deterioration in cortical function during insulin-induced hypoglycemia. Diabetes (1985) 1.05
Improved specificity of ICA assays in the Fourth International Immunology of Diabetes Serum Exchange Workshop. Diabetes (1992) 1.04
Jet-injected insulin is associated with decreased antibody production and postprandial glucose variability when compared with needle-injected insulin in gestational diabetic women. Diabetes Care (1993) 1.04
Cellular immune responses to human islet proteins in antibody-positive type 2 diabetic patients. Diabetes (1999) 1.02
Latent autoimmune diabetes in adults (LADA) is dead: long live autoimmune diabetes! Diabetologia (2010) 1.01
Improving the quality of outpatient care for older patients with diabetes: lessons from a comparison of rural and urban communities. J Fam Pract (2001) 1.01
Immunology in the Clinic Review Series; focus on metabolic diseases: development of islet autoimmune disease in type 2 diabetes patients: potential sequelae of chronic inflammation. Clin Exp Immunol (2012) 1.00
Glucagon response to hypoglycemia in sympathectomized man. J Clin Invest (1976) 0.98
Alterations in lymphocyte subpopulations in type 1 (insulin-dependent) diabetes mellitus: exploration of possible mechanisms and relationships to autoimmune phenomena. Diabetologia (1984) 0.98
Predictive value of islet cell and insulin autoantibodies for type 1 (insulin-dependent) diabetes mellitus in a population-based study of newly-diagnosed diabetic and matched control children. Diabetologia (1992) 0.97
Glucagon and catecholamine secretion during hypoglycemia in normal and diabetic man. J Clin Endocrinol Metab (1977) 0.97
Nicotinamide's effects on glucose metabolism in subjects at risk for IDDM. Diabetes (1996) 0.96
The bimodal effect of interleukin 1 on rat pancreatic beta-cells--stimulation followed by inhibition--depends upon dose, duration of exposure, and ambient glucose concentration. Acta Endocrinol (Copenh) (1988) 0.95
Insulin autoantibodies and insulin antibodies have similar binding characteristics. Proc Assoc Am Physicians (1999) 0.94
Acute-phase insulin secretion and glucose tolerance in young and aged normal men and diabetic patients. J Clin Endocrinol Metab (1975) 0.94
Absence of glutamic acid decarboxylase antibodies in Pima Indian children with diabetes mellitus. Diabetologia (1999) 0.94
Heterogeneity of islet pathology in two infants with recent onset diabetes mellitus. Virchows Arch (1995) 0.93
Risk for developing type 1 (insulin-dependent) diabetes mellitus and the presence of islet 64K antibodies. Diabetologia (1991) 0.93
Type 1 1/2 diabetes: myth or reality? Autoimmunity (1999) 0.93
Interleukin 2 inhibits antigen-stimulated lymphokine synthesis in helper T cells by inhibiting calcium-dependent signalling. J Immunol (1987) 0.93
Beta-cell dysfunction in nondiabetic HLA identical siblings of insulin-dependent diabetics. Diabetes (1982) 0.92
Effects of an anti-CD5 immunoconjugate (CD5-plus) in recent onset type I diabetes mellitus: a preliminary investigation. The CD5 Diabetes Project Team. J Diabetes Complications (1993) 0.92
Islet cell antibodies and glutamic acid decarboxylase antibodies, but not the clinical phenotype, help to identify type 1(1/2) diabetes in patients presenting with type 2 diabetes. Metabolism (2001) 0.92
Activation of lymphokine genes during stimulation of cloned T cells. Eur J Immunol (1986) 0.91
The association between the PTPN22 1858C>T variant and type 1 diabetes depends on HLA risk and GAD65 autoantibodies. Genes Immun (2010) 0.91
Association between autoantibody markers and subtypes of DR4 and DR4-DQ in Swedish children with insulin-dependent diabetes reveals closer association of tyrosine pyrophosphatase autoimmunity with DR4 than DQ8. Tissue Antigens (1998) 0.91
Glucose regulation of glucagon secretion independent of B cell activity. Metabolism (1983) 0.90
Outbreak of Pasteurella pneumotropica in a closed colony of STOCK-Cd28(tm1Mak) mice. Contemp Top Lab Anim Sci (2000) 0.88
Reduction of plasma triglyceride concentration by acute stress in man. Metabolism (1979) 0.88
Nonprogression of subclinical beta-cell dysfunction among first-degree relatives of IDDM patients. 5-yr follow-up of the Seattle Family Study. Diabetes (1990) 0.87
Low-dose interleukin 1 and tumor necrosis factor individually stimulate insulin release but in combination cause suppression. Eur J Endocrinol (1994) 0.87
Evaluation of the control of glucagon secretion by the parasympathetic nervous system in man. Metabolism (1979) 0.86
Genetic and immunological markers of insulin dependent diabetes in Black Americans. Autoimmunity (1995) 0.86
Insulin antibodies and insulin autoantibodies. Diabet Med (1991) 0.85
Effect of nicotinic acid-induced insulin resistance on pancreatic B cell function in normal and streptozocin-treated baboons. J Clin Invest (1991) 0.85
The functional state of the beta cell modulates IL-1 and TNF-induced cytotoxicity. Lymphokine Cytokine Res (1993) 0.85
Changes in GAD65Ab-specific antiidiotypic antibody levels correlate with changes in C-peptide levels and progression to islet cell autoimmunity. J Clin Endocrinol Metab (2010) 0.85
Glucose modulation of insulin and glucagon secretion in nondiabetic and diabetic man. Diabetes (1982) 0.85
Immunoreactive glucagon responses to oral glucose, insulin infusion and deprivation, and somatostatin in pancreatectomized man. Diabetes (1978) 0.85
Functional state of the beta cell affects expression of both forms of glutamic acid decarboxylase. Pancreas (1994) 0.84
Attenuation of islet-specific T cell responses is associated with C-peptide improvement in autoimmune type 2 diabetes patients. Clin Exp Immunol (2013) 0.84
Effect of insulin resistance and hyperglycemia on proinsulin release in a primate model of diabetes mellitus. J Clin Endocrinol Metab (1992) 0.84
Metabolic state of the pancreas affects end-point titre in the islet cell antibody assay. Diabetologia (1991) 0.83
Alterations in the patterns of insulin secretion before and after diagnosis of IDDM. Diabetes Care (1995) 0.83
Glucagon deficiency and hyperaminoacidemia after total pancreatectomy. J Clin Invest (1980) 0.83
Epitope analysis of insulin autoantibodies using recombinant Fab. Clin Exp Immunol (2005) 0.82
Islet autoimmunity in phenotypic type 2 diabetes patients. Diabetes Obes Metab (2013) 0.81
Stimulation of glucagon secretion by ethanol-induced hypoglycemia in man. Diabetes (1975) 0.81
Evaluation of a novel radioimmunoassay using 125I-labelled human recombinant GAD65 for the determination of glutamic acid decarboxylase (GAD65) autoantibodies. Int J Clin Lab Res (2000) 0.81
Glucose counterregulation in patients after pancreatectomy. Comparison with other clinical forms of diabetes. Diabetes (1984) 0.81
Beta-cell function and insulin sensitivity in nondiabetic HLA-identical siblings of insulin-dependent diabetics. Diabetes (1987) 0.80
Systematic variation and differences in insulin-autoantibody measurements. Diabetes (1989) 0.80
Glycosylated hemoglobin and psychological adjustment in adolescents with diabetes. Adolescence (1991) 0.80
The Third International Workshop on the Standardisation of Insulin Autoantibody Measurement. Diabetologia (1990) 0.80
Relapsing and remitting severe hypoglycemia due to a monoclonal anti-insulin antibody heralding a case of multiple myeloma. J Clin Endocrinol Metab (2012) 0.80
Glucagon responses to hypoglycemia in adrenalectomized man. Metabolism (1976) 0.80
Transplantation of the islets of Langerhans: new hope for treatment of type 1 diabetes mellitus. Trends Endocrinol Metab (2000) 0.79
The Fourth International Workshop on the Standardisation of Insulin Autoantibody Workshop. Diabetologia (1990) 0.79
Analysis of human biologics with a mouse skin transplant model in humanized mice. Am J Transplant (2012) 0.79
Fifth International Serum Exchange Workshop for Insulin Autoantibody (IAA) Standardization. The Immunology and Diabetes Workshops and participating laboratories. Diabetologia (1992) 0.79
Farewell to phenformin for treating diabetes mellitus. Ann Intern Med (1975) 0.79
Systematic approach to diagnosis and management of biphasic insulin allergy with local anti-inflammatory agents. Diabetes Care (1989) 0.78
Diabetes mellitus and skeletal fracture. JAMA (1983) 0.78
Interleukin 2 and concanavalin A stimulate interferon-gamma production in a murine cytolytic T cell clone by different pathways. J Immunol (1987) 0.78
Autonomic nervous system control of glucagon secretion during neuroglucopenia. Endocrinology (1983) 0.77
Antibodies to viruses and to pancreatic islets in nondiabetic and insulin-dependent diabetic patients. Diabetes Care (1982) 0.77
Hepatic glucagon clearance during insulin induced hypoglycemia. Horm Metab Res (1986) 0.77